As part of NEI’s longstanding active ownership programme, Michela spearheads NEI’s engagement dialogues with pharmaceutical companies on access considerations, systemic inequity and other ESG issues. She is also actively involved in a number of collaborative investor engagements with companies.
Prior to joining NEI, Michela was based in Ghana with an impact investor focused on early-stage investment in sub-Saharan Africa. She is a lawyer by trade, and practiced plaintiff-side class actions law in Canada across various legal issues. She holds a B.A. in Honours Business Administration from the Ivey Business School and a J.D. from Osgoode Hall Law School, York University.